Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Summary of author experiences with alemtuzumab
| National approval/reimbursement period | September 2013–May 2015 |
| Patients treated, N | 181 |
| Female, n (%) | 129 (71) |
| Age, mean (range), years | 35 (17–66) |
| Alemtuzumab as: | |
| First-line therapy, n (%) | 27 (15) |
| Escalation therapy, n (%) | 154 (85) |
Data provided courtesy of the authors and represents a summary of the experiences in Austria, Finland, Germany, Ireland, Italy, Norway, and Spain
